Selected Publications
Traynor AM, Hewitt M, Liu G, Flaherty KT, Clark J, Freedman SJ, Leighton AM, Watson PA, Zhao B, O'Dwyer PJ, Wilding G.: Phase I dose escalation study of MK-0457, a novel Aurora kinase inhibitor, in adult patients with advanced tumors.
Cancer Chemother Pharmacol : 2010.
Hewitt MR, Sun W.: Oxaliplatin-Associated Hypersensitivity Reactions: Clinical Presentation and Management Clinical Colorectal Cancer 2 (6): 114-117,2006.
Hewitt M, Sun W, Haller DG, Mykulowycz K, Tuite C, Rosen M, Caparro M, Giantonio B, Oltoff K.: A phase II trial of the Combination of Capecitabine, Oxaliplatin with Bevacuzynab in the Treatment of Advanced Hepatocellular Carcinoma Preliminary Safety Analysis. Proceedings of the American Society of Clinical Oncology : 2006.
Hewitt MR, Haller DG.: Adjuvant Therapy for Colon Cancer, Yesterday, Today and Tomorrow The Article Reviewed Oncology (Williston Park) 20 : 473-475,2006.
Hewitt MR, Yu K.: Treatment Update for Metastatic Pancreatic Cancer Community Oncology 3 : 28-430,2006.
Hewitt M, Porter DL, Hummel K, McAlee A, Phillips J, Stadtmauer E, Schuster S, Luger S, Nasta S, Tsai D, Loren A, Perl A, Emerson S, Goldstein SC.: Myeloablative vs. Non-Myeloablative Conditioning with Allogeneic Stem Cell Transplantation for High Risk Non-Hodgkin's Lymphoma. Similar Outcomes Despite Differences in Disease Risk Proceedings of the American Society of Bone Marrow Transplantation : 2005.
DeCoster MA, Hewitt MR, Lambeau M, Lascunski M, Bazan NG: Modulation of Neuronal Sensitivity to Glutamate by Secretory Phospholipases A2 (SPLA2s) Proceedings of the Society for Neuroscience : 1997.
Academic Contact Information
Penn Hematology/Oncology
Suite 201
440 East Marshall Street
West Chester,
PA
19380
Phone: 610-738-2500
Patient appointments: 800-789-7366